Let's talk medical research

Increasingly, medical researchers acknowledge the need for more diversity in study participants so that trials can better predict the real-world impact of a drug or medical device. Yet a big question remains: How can researchers better reach diverse populations to drive minority participation in medical research?

Minority participation in medical research is important for all conditions, but is critical for ailments that disproportionately impact people of color, like lupus.

In the end, it was vanity that brought Shanelle Gabriel to the doctor who diagnosed her lupus. At least that’s how she tells it.

The hall was full of people clad in conference attire: black suits, white shirts, and, for some, an adventurous pop of color in a shoe or a tie.

On March 6th, Antidote’s partners Lupus and Allied Diseases Association and Lupus Research Alliance, along with the Lupus Foundation of America, released the Lupus Patient Voices report.

“I have a vision of a world where every single child with a rare disease has a treatment option," said Erica Barnes, founder of Chloe's Fight Rare Disease Foundation.

“The arsenal of weapons to fight melanoma has increased drastically in the 10 years since my wife lost her battle. People diagnosed today have a real chance of having their tumors disappear.”- Neil Spiegler, President of the Melanoma Action Coalition and Founder of The Peggy Spiegler Melanoma Research Foundation.